The Translational Research Partnership (TRP) between Case Western Reserve and the Wallace H. Coulter Foundation fosters collaborations among clinicians and Biomedical Engineering faculty on translational research projects with the potential to impact patient care. The program is led by Robert Kirsch, Ph.D, chairman of the Department of Biomedical Engineering and Stephen Fening, PhD, Coutler Program Director.
CWRU was one of nine universities selected in 2006 by the Wallace H. Coulter Foundation (WHCF) for a Translational Research Partnership award. A grant of $4.58 million established the initial 5-year phase of the TRP within the Biomedical Engineering Department. The TRP is a platform to promote translational research and to support collaborative translational research projects to address unmet or poorly met clinical needs. An overarching goal of the program is to improve patient care and accelerate the delivery of healthcare technology from academia to the marketplace; of particlar interest is research and development work likely leading to commercially relevant translational technologies within a 3-5 year horizon. The TRP typcially sponsors between 6-8 "full" collaborative translational research projects (receiving up to $200,000) annually and multiple pilot projects. Over the 5-year initial period the program at Case Western Reserve helped launch six startup companies and funded 62 translational research activities. Projects often range across a broad spectrum of biomedical disciplines - from advanced imaging technology techniques to thermally-stable insulin development - and each is founded on an active collaboration between a biomedical engineering researcher and a practicing clinician.
On November 1, 2011 CWRU and the Coulter Foundation announced the establishment of a $20 million endowment to continue support for the TRP. Among other activities, the day-long endowment celebration featured an award ceremony, media coverage by MedCityNews, and a presentation by Sue Van, president of the Coulter Foundation, to faculty, staff and students.
We are pleased to be in our 4th year of Phase 2 of the Translational Research Partnership. Details on the upcoming PY2015 briefing sessions are presented here, but please feel free to contact any of the TRP program leadership for more information or a 1-on-1 meeting.
TRP is a unique bioengineering initiative addressing unmet clinical needs through translational research. Since project objectives reflect the fundamental goal to improve patient care, TRP projects are structured as collaborative efforts involving co-investigators from CWRU Biomedical Engineering and a clinical department (typically within a school of medicine). Unlike basic research (the creation of new knowledge), translational research is centered more on the practical clinical application of research results. Project discussions therefore involve consideration of potential protectable intellectual property, commercialization, product development, marketing, sales, and production. Proposed translational research projects are often quite unlike what BME researchers might typically submit to, say, the National Institutes of Health. The process of project selection, guidance, and mentoring is an important and critical role of the Oversight Committee (OC) ; membership and stakeholder representation might seem unusual within a typical university “committee” setting, but reflects the unique CCTRP theme.
For more information on the TRP, technology available for licensing or commercialization, awards, project information, or proposal deadlines, you can navigate this site using the menu on the left, or contact the TRP program leadership and we would be pleased to answer any questions you may have!
Story of Wallace H. Coulter
The legacy of Wallace H. Coulter is continued in the Wallace H. Coulter foundation. Click here to learn more about the man behind the foundation.